Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04165070
Title Substudy 1: Efficacy and Safety Study of Pembrolizumab (MK-3475) Plus Chemotherapy When Used With Investigational Agents in Treatment-naive Participants With Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYNOTE-01A)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center ( Site 0001) Gilbert Arizona 85234 United States Details
City of Hope ( Site 0014) Duarte California 91010 United States Details
UCSF Medical Center at Mission Bay ( Site 0007) San Francisco California 94158 United States Details
Georgetown University ( Site 0036) Washington District of Columbia 20007 United States Details
University of Kentucky Markey Cancer Center ( Site 0019) Lexington Kentucky 40536-0293 United States Details
MedStar Franklin Square Medical Center ( Site 0033) Baltimore Maryland 21237 United States Details
Massachusetts General Hospital ( Site 0003) Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute ( Site 0002) Boston Massachusetts 02215 United States Details
Oncology Hematology West, PC DBA Nebraska Cancer Specialists ( Site 0031) Omaha Nebraska 68130 United States Details
Dartmouth Hitchcock Medical Center ( Site 0016) Lebanon New Hampshire 03766 United States Details
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0037) Hackensack New Jersey 07601 United States Details
Laura and Isaac Perlmutter Cancer Center ( Site 0034) New York New York 10016 United States Details
Sanford Fargo Medical Center ( Site 0039) Fargo North Dakota 58102 United States Details
Cleveland Clinic ( Site 0006) Cleveland Ohio 44195 United States Details
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C Columbus Ohio 43210 United States Details
Abramson Cancer Center of the University of Pennsylvania ( Site 0010) Philadelphia Pennsylvania 19104 United States Details
Sanford Cancer Center ( Site 0038) Sioux Falls South Dakota 57104 United States Details
The University of Texas MD Anderson Cancer Center ( Site 0009) Houston Texas 77030 United States Details
Petz Aladar Megyei Oktato Korhaz ( Site 0062) Gyor Gyor-Moson-Sopron 9024 Hungary Details
Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház ( Site 0061) Szolnok Jasz-Nagykun-Szolnok 5000 Hungary Details
Orszagos Koranyi Pulmonologiai Intezet ( Site 0060) Budapest 1121 Hungary Details
Soroka Medical Center ( Site 0072) Beer-Sheva 8457108 Israel Details
Rambam Health Care Campus-Oncology ( Site 0076) Haifa 3109601 Israel Details
Shaare Zedek Medical Center ( Site 0075) Jerusalem 9103102 Israel Details
Meir Medical Center ( Site 0071) Kfar-Saba 4428132 Israel Details
Rabin Medical Center ( Site 0074) Petah Tikva 4941492 Israel Details
Chaim Sheba Medical Center ( Site 0070) Ramat Gan 5262000 Israel Details
Sourasky Medical Center ( Site 0077) Tel Aviv 64239 Israel Details
Azienda Ospedaliera Universitaria Careggi ( Site 0173) Florence Firenze 50134 Italy Details
Policlinico Gemelli di Roma ( Site 0174) Roma Lazio 00168 Italy Details
IRCCS Ospedale San Raffaele ( Site 0171) Milano 20132 Italy Details
Seoul National University Bundang Hospital ( Site 0081) Seongnam-si Kyonggi-do 13620 Korea, Republic of Details
Severance Hospital ( Site 0080) Seoul 03722 Korea, Republic of Details
Samsung Medical Center ( Site 0082) Seoul 06351 Korea, Republic of Details
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier Warszawa Mazowieckie 02-781 Poland Details
Uniwersyteckie Centrum Kliniczne-Early Clinical Trials Unit ( Site 0150) Gdańsk Pomorskie 80-952 Poland Details
Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 0152) Koszalin Zachodniopomorskie 75-581 Poland Details
ICO L Hospitalet ( Site 0090) Hospitalet de Llobregat Barcelona 08907 Spain Details
Hospital Universitario Quiron Madrid ( Site 0091) Pozuelo de Alarcon Madrid 28223 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field